164 related articles for article (PubMed ID: 19212424)
1. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity.
Funke S; Schneider IC; Glaser S; Mühlebach MD; Moritz T; Cattaneo R; Cichutek K; Buchholz CJ
Gene Ther; 2009 May; 16(5):700-5. PubMed ID: 19212424
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
[TBL] [Abstract][Full Text] [Related]
3. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.
Frecha C; Lévy C; Costa C; Nègre D; Amirache F; Buckland R; Russell SJ; Cosset FL; Verhoeyen E
J Virol; 2011 Jun; 85(12):5975-85. PubMed ID: 21450813
[TBL] [Abstract][Full Text] [Related]
4. Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells.
Humbert JM; Frecha C; Amirache Bouafia F; N'Guyen TH; Boni S; Cosset FL; Verhoeyen E; Halary F
J Virol; 2012 May; 86(9):5192-203. PubMed ID: 22345444
[TBL] [Abstract][Full Text] [Related]
5. Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins.
Schoenhals M; Frecha C; Bruyer A; Caraux A; Veyrune JL; Jourdan M; Moreaux J; Cosset FL; Verhoeyen E; Klein B
Leukemia; 2012 Jul; 26(7):1663-70. PubMed ID: 22318450
[TBL] [Abstract][Full Text] [Related]
6. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
7. Targeted cell entry of lentiviral vectors.
Funke S; Maisner A; Mühlebach MD; Koehl U; Grez M; Cattaneo R; Cichutek K; Buchholz CJ
Mol Ther; 2008 Aug; 16(8):1427-36. PubMed ID: 18578012
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.
Sinn PL; Coffin JE; Ayithan N; Holt KH; Maury W
Methods Mol Biol; 2017; 1628():65-78. PubMed ID: 28573611
[TBL] [Abstract][Full Text] [Related]
9. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
10. A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.
Marino MP; Panigaj M; Ou W; Manirarora J; Wei CH; Reiser J
Gene Ther; 2015 Mar; 22(3):280-5. PubMed ID: 25608718
[TBL] [Abstract][Full Text] [Related]
11. Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM.
Zhou Q; Schneider IC; Gallet M; Kneissl S; Buchholz CJ
Virology; 2011 May; 413(2):149-52. PubMed ID: 21470651
[TBL] [Abstract][Full Text] [Related]
12. Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping.
Kim SH; Lim KI
Mol Cells; 2017 May; 40(5):339-345. PubMed ID: 28535668
[TBL] [Abstract][Full Text] [Related]
13. Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing.
Radek C; Bernadin O; Drechsel K; Cordes N; Pfeifer R; Sträßer P; Mormin M; Gutierrez-Guerrero A; Cosset FL; Kaiser AD; Schaser T; Galy A; Verhoeyen E; Johnston ICD
Hum Gene Ther; 2019 Dec; 30(12):1477-1493. PubMed ID: 31578886
[TBL] [Abstract][Full Text] [Related]
14. Altering the tropism of lentiviral vectors through pseudotyping.
Cronin J; Zhang XY; Reiser J
Curr Gene Ther; 2005 Aug; 5(4):387-98. PubMed ID: 16101513
[TBL] [Abstract][Full Text] [Related]
15. Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.
Frecha C; Costa C; Nègre D; Gauthier E; Russell SJ; Cosset FL; Verhoeyen E
Blood; 2008 Dec; 112(13):4843-52. PubMed ID: 18812471
[TBL] [Abstract][Full Text] [Related]
16. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
[TBL] [Abstract][Full Text] [Related]
17. Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.
Carpentier DC; Vevis K; Trabalza A; Georgiadis C; Ellison SM; Asfahani RI; Mazarakis ND
Gene Ther; 2012 Jul; 19(7):761-74. PubMed ID: 21900965
[TBL] [Abstract][Full Text] [Related]
18. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells.
Strang BL; Takeuchi Y; Relander T; Richter J; Bailey R; Sanders DA; Collins MK; Ikeda Y
J Virol; 2005 Feb; 79(3):1765-71. PubMed ID: 15650201
[TBL] [Abstract][Full Text] [Related]
20. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
Kumar M; Bradow BP; Zimmerberg J
Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
